Table 2.
A | Promoters | Enhancers | ||||
CGI | Non-CGI | P-value | CGI | Non-CGI | P-value | |
Overall | 0.278 | 0.771 | <10−300 | 0.795 | 0.944 | <10−300 |
B | Promoters | Enhancers | ||||
TATA+ | TATA− | P-value | TATA+ | TATA− | P-value | |
Overall | 0.726 | 0.480 | 1.9 × 10−77 | 0.961 | 0.939 | 1.1 × 10−131 |
CGI | 0.482 | 0.269 | 1.7 × 10−22 | 0.878 | 0.791 | 7.3 × 10−8 |
Non-CGI | 0.820 | 0.761 | 1.7 × 10−9 | 0.962 | 0.942 | 3.6 × 10−108 |
The table shows τ medians of different subsets of promoters and enhancers. (A) τ medians according to CGI status. (B) τ medians for CGI and non-CGI promoters and enhancers according to the presence (TATA+) or absence (TATA−) of a TATA box. P-values were calculated with the Mann–Whitney U test. The values are derived from tissue data.